DermaTran Health Solutions, its related pharmacy billing company, and three retail pharmacies agreed to pay more than $6.8 million to settle alleged violations of the False Claims Act for charging patients in federal health programs extra for pain relief creams.
Adrianne Appel
Adrianne Appel writes regulatory news, policy, and trends for Compliance Week. She previously reported about policy developments for Bloomberg Law and Bloomberg Government.
Email: adrianne.appel@complianceweek.com
LinkedIn: Follow
Ex-CCO sentenced to six-plus years in prison for role in Ponzi scheme
Vania May Bell, the former chief compliance officer and comptroller at Executive Compensation Planners, was sentenced to more than six years in prison for her role in a Ponzi scheme that defrauded clients of more than $11 million.
Bittrex to pay $29M for BSA violations in landmark FinCEN, OFAC case
Virtual currency trading platform Bittrex agreed to pay more than $29 million for violations of the Bank Secrecy Act and other foreign asset restrictions by regularly allowing transactions with customers in Iran, Syria, and other U.S.-sanctioned nations.
Pharma, whistleblower lessons learned from $900M Biogen settlement
Experts discuss the ramifications of Biogen’s $900 million settlement for False Claims Act violations, including the $266.4 million whistleblower bounty in the case believed to be the largest single award under any government program.
NetWalker hacker imprisoned 20 years for ransomware attacks
Sebastien Vachon-Desjardins, a former Canadian government employee who played part in widespread NetWalker ransomware attacks, was sentenced to 20 years in prison and ordered to forfeit the $21.5 million U.S. investigators said he received from his victims.
Samsung facing class action alleging CCPA violations over data breaches
Samsung collected too much personal data from customers and failed to adequately secure it, leading to two data breaches this year and potentially millions of harmed individuals, a class-action lawsuit alleges.
Infinity Q CCO settles SEC charges of aiding $1B fraud scheme
Scott Lindell, the former chief risk officer and chief compliance officer of Infinity Q Capital Management, settled SEC charges he helped conceal the founder of the investment adviser carried out a $1 billion overvaluation fraud scheme.
SEC charges pharma CEO, two companies with offering fraud
The Securities and Exchange Commission charged Paul Edalat and two pharmaceuticals companies he controlled—Sentar and Vivera—with engaging in a fraudulent investment scheme.
Tupperware Brands fined $900K for accounting failures at Mexico unit
Tupperware Brands Corp. agreed to pay $900,000 to settle SEC charges of failing to maintain sufficient internal accounting controls and keep accurate books and records at its Mexico affiliate.
Deloitte China fined $20M for ‘basic’ audit standard violations
The Chinese affiliate of Big Four audit firm Deloitte agreed to pay a $20 million penalty and undertake extensive remedial measures as part of a settlement with the SEC for audit failures that included asking clients to conduct their own audit work.


